Study GSUS2920119 ECFTAF DRV 800 mg QD N 89 N 46 Baseline regimen Design Randomisation 2 1 Openlabel Objective Primary Endpoint proportion with treatment success HIV RNA lt 50 cmL ID: 613749
Download Presentation The PPT/PDF document "Switch to E/C/F/TAF + DRV" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
